UBS AM
LFST icon

UBS AM’s Lifestance Health LFST Stock Holding History

UBS AM’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.8M Sell
6,092,223
-25,804
-0.4% -$180K 0.01% 681
2025
Q4 		$43.1M Buy
6,118,027
+1,324,691
+28% +$7.99M 0.01% 641
2025
Q3 		$26.4M Buy
4,793,336
+1,839,465
+62% +$9.01M 0.01% 741
2025
Q2 		$15.3M Buy
2,953,871
+2,338,219
+380% +$14M ﹤0.01% 1154
2025
Q1 		$4.1M Buy
615,652
+11,331
+2% +$86.1K ﹤0.01% 1667
2024
Q4 		$4.45M Buy
604,321
+87,502
+17% +$628K ﹤0.01% 1663
2024
Q3 		$3.62M Buy
516,819
+48,634
+10% +$292K ﹤0.01% 1738
2024
Q2 		$2.3M Buy
468,185
+164,725
+54% +$993K ﹤0.01% 1925
2024
Q1 		$1.87M Buy
303,460
+79,452
+35% +$535K ﹤0.01% 1717
2023
Q4 		$1.75M Buy
224,008
+172,461
+335% +$1.11M ﹤0.01% 1756
2023
Q3 		$354K Buy
+51,547
New +$418K ﹤0.01% 2393
2021
Q3 		– Sell
-89,399
Closed -$2.49M – 2763
2021
Q2 		$2.49M Buy
+89,399
New +$2.36M ﹤0.01% 1754

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM's LFST Position: Q1 2026 in Review

UBS AM reduced its Lifestance Health (LFST) stake by 0.42% in Q1 2026, selling an estimated $180K and leaving 6,092,223 shares worth $38.8M. The position accounts for 0.01% of the portfolio, ranked #681.

UBS AM first reported a position in LFST in Q2 2021 and has held it in 12 quarters since. The position peaked at $43.1M in Q4 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • UBS AM held 6,092,223 shares of Lifestance Health worth $38.8M as of Q1 2026.
  • UBS AM sold 25,804 Lifestance Health shares in Q1 2026, an estimated $180K.
  • Lifestance Health made up 0.01% of UBS AM's portfolio in Q1 2026, its #681 holding.
  • UBS AM first reported a position in Lifestance Health in Q2 2021 and has held it in 12 quarters since.
  • UBS AM's Lifestance Health position peaked at $43.1M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.